AuctuCel Launches AuctuPrime to Reduce Biological Variability in Cell Therapy Manufacturing
8 Articles
8 Articles
NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing
/PRNewswire/ -- NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational...
AuctuCel launches AuctuPrime to reduce biological variability in cell therapy manufacturing
Chemically defined medium removes animal serum and human platelet supplements as Malaysia and Singapore strengthen advanced therapy capabilities SINGAPORE - Media OutReach...
AuctuCel launches AuctuPrime for cell therapy manufacturing
SINGAPORE - Media OutReach Newswire - 4 August 2026 -Singapore is estimated to record approximately 19,290 new cancer cases in 2024, underscoring the growing demand for advanced treatment options and the manufacturing systems needed to produce them consistently. As cell therapies move from research towards clinical use, the reliability of every raw material used in production becomes increasingly important. AuctuCel Pte Ltd, a Singapore biotechn…
AuctuCel launches AuctuPrime to reduce biological variability in cell
Chemically defined medium removes animal serum and human platelet supplements as Malaysia and Singapore strengthen advanced therapy capabilities SINGAPORE – Media OutReach Newswire – 4 August 2026 –Singapore is estimated to record approximately 19,290 new cancer cases in 2024, underscoring the growing demand for advanced treatment options and the manufacturing systems needed to produce them […]
Cryopreservation in cell therapy: Reducing variability from the start
Learn why cryopreservation is becoming essential for scalable, standardized cell therapy manufacturing and commercialization. The post Cryopreservation in cell therapy: Reducing variability from the start appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be …
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium



